Literature DB >> 29305224

SNPitty: An Intuitive Web Application for Interactive B-Allele Frequency and Copy Number Visualization of Next-Generation Sequencing Data.

Job van Riet1, Niels M G Krol2, Peggy N Atmodimedjo3, Erwin Brosens4, Wilfred F J van IJcken5, Maurice P H M Jansen6, John W M Martens6, Leendert H Looijenga3, Guido Jenster7, Hendrikus J Dubbink3, Winand N M Dinjens3, Harmen J G van de Werken8.   

Abstract

Exploration and visualization of next-generation sequencing data are crucial for clinical diagnostics. Software allowing simultaneous visualization of multiple regions of interest coupled with dynamic heuristic filtering of genetic aberrations is, however, lacking. Therefore, the authors developed the web application SNPitty that allows interactive visualization and interrogation of variant call format files by using B-allele frequencies of single-nucleotide polymorphisms and single-nucleotide variants, coverage metrics, and copy numbers analysis results. SNPitty displays variant alleles and allelic imbalances with a focus on loss of heterozygosity and copy number variation using genome-wide heterozygous markers and somatic mutations. In addition, SNPitty is capable of generating predefined reports that summarize and highlight disease-specific targets of interest. SNPitty was validated for diagnostic interpretation of somatic events by showcasing a serial dilution series of glioma tissue. Additionally, SNPitty is demonstrated in four cancer-related scenarios encountered in daily clinical practice and on whole-exome sequencing data of peripheral blood from a Down syndrome patient. SNPitty allows detection of loss of heterozygosity, chromosomal and gene amplifications, homozygous or heterozygous deletions, somatic mutations, or any combination thereof in regions or genes of interest. Furthermore, SNPitty can be used to distinguish molecular relationships between multiple tumors from a single patient. On the basis of these data, the authors demonstrate that SNPitty is robust and user friendly in a wide range of diagnostic scenarios.
Copyright © 2018 American Society for Investigative Pathology and the Association for Molecular Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29305224     DOI: 10.1016/j.jmoldx.2017.11.011

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  5 in total

1.  Radiotherapy resistance in chondrosarcoma cells; a possible correlation with alterations in cell cycle related genes.

Authors:  Yvonne de Jong; Martha Ingola; Inge H Briaire-de Bruijn; Alwine B Kruisselbrink; Sanne Venneker; Ieva Palubeckaite; Bram P A M Heijs; Anne-Marie Cleton-Jansen; Rick L M Haas; Judith V M G Bovée
Journal:  Clin Sarcoma Res       Date:  2019-05-28

2.  First maternal uniparental disomy for chromosome 2 with PREPL novel frameshift mutation of congenital myasthenic syndrome 22 in an infant.

Authors:  Ping Zhang; Bingbing Wu; Yulan Lu; Qi Ni; Renchao Liu; Wenhao Zhou; Huijun Wang
Journal:  Mol Genet Genomic Med       Date:  2020-01-27       Impact factor: 2.183

3.  Malignant transformation of salivary gland pleomorphic adenoma: proof of principle.

Authors:  Matthijs H Valstar; Hetty Mast; Ivo Ten Hove; Laura R Moonen; Alfons Jm Balm; Ludi E Smeele; Senada Koljenović; Winand Nm Dinjens; Marie-Louise F van Velthuysen
Journal:  J Pathol Clin Res       Date:  2021-05-07

4.  The role of AIP variants in pituitary adenomas and concomitant thyroid carcinomas in the Netherlands: a nationwide pathology registry (PALGA) study.

Authors:  E Korpershoek; S J C M M Neggers; E C Coopmans; A Muhammad; A F Daly; W W de Herder; F J van Kemenade; A Beckers; M de Haan; A J van der Lely
Journal:  Endocrine       Date:  2020-04-24       Impact factor: 3.633

5.  The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladder.

Authors:  Thomas van Doeveren; Jose A Nakauma-Gonzalez; Andrew S Mason; Geert J L H van Leenders; Tahlita C M Zuiverloon; Ellen C Zwarthoff; Isabelle C Meijssen; Angelique C van der Made; Antoine G van der Heijden; Kees Hendricksen; Bas W G van Rhijn; Charlotte S Voskuilen; Job van Riet; Winand N M Dinjens; Hendrikus J Dubbink; Harmen J G van de Werken; Joost L Boormans
Journal:  Int J Cancer       Date:  2020-10-13       Impact factor: 7.396

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.